Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 198
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
LETTER TO THE EDITOR
Year : 2015  |  Volume : 4  |  Issue : 2  |  Page : 293

Gastrointestinal stromal tumors: Indian perspective


1 Department of Pathology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
2 Department of Surgical Gastroenterology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
3 Department of Surgical Oncology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India

Date of Web Publication9-Mar-2015

Correspondence Address:
Rashmi Patnayak
Department of Pathology, Sri Venkateswara Institute of Medical Sciences, Tirupati - 517 507, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-0513.152752

Rights and Permissions

How to cite this article:
Patnayak R, Reddy V, Parthasarathy S, Jena A, Reddy MK. Gastrointestinal stromal tumors: Indian perspective. Clin Cancer Investig J 2015;4:293

How to cite this URL:
Patnayak R, Reddy V, Parthasarathy S, Jena A, Reddy MK. Gastrointestinal stromal tumors: Indian perspective. Clin Cancer Investig J [serial online] 2015 [cited 2020 Apr 7];4:293. Available from: http://www.ccij-online.org/text.asp?2015/4/2/293/152752

Sir,

We have read the article "gastrointestinal stromal tumors (GISTs): A single institute experience from South India". By Lakshmaiah et al. with interest. [1]

Recently, there has been renewed interest and surge of literature regarding these set of tumors with the introduction of the marker CD117. In a study conducted in our department, we have also encountered stomach as the most common site, followed by small intestine. [2] Majority of the patients belonged to fourth to the fifth decade of life. In our patients, gastrointestinal bleeding was a predominant finding. The GISTs were of high risk category and majority had spindle cell morphology. Similar to the findings by the authors we have observed CD117 positivity in all the tumors categorized as GIST. All of them also showed CD34 positivity in our study group. However, discovered on GIST-1 marker was not done in our study. [2]

The present study provides valuable insight into the therapeutic aspect. A multi-institutional study taking into account various clinicopathological findings is desirable.

 
  References Top

1.
Lakshmaiah KC, Suresh TM, Babu G, Babu S, Purohit S, Guruprasad B, et al. Gastrointestinal stromal tumors: A single institute experience from South India. Clin Cancer Invest J 2014;3:62-5.  Back to cited text no. 1
    
2.
Patnayak R, Jena A, Prasad PD, Rukhamangadha N, Chowhan AK, Parthasarathy S, et al. Evaluation of mesenchymal tumors of gastrointestinal tract with special reference to gastrointestinal stromal tumors - A tertiary care center experience. Oncol Gastroenterol Hepatol Rep 2013;2:52-7.  Back to cited text no. 2
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References

 Article Access Statistics
    Viewed815    
    Printed18    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal